Changes in regional brain morphology in neuropsychiatric systemic lupus erythematosus

Journal of Rheumatology

Volumn 39, Issue 5, 2012, Pages 959-967

  Cagnoli, Patricia C ^a   Sundgren, Pia C ^a,b   Kairys, Anson ^a   Graft, Courtney C ^a   Clauw, Daniel J ^a   Gebarski, Stephen ^a   McCune, W Joseph ^a   Schmidt Wilcke, Tobias ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Brain morphology; Neuropsychiatric lupus; Systemic lupus erythematosus; Thalamus; Voxel based morphometry

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG PULSE THERAPY; FEMALE; GRAY MATTER; HUMAN; MALE; MENTAL DISEASE; NEUROIMAGING; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAHIPPOCAMPAL GYRUS; PARIETAL LOBE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL LOBE; THALAMUS POSTERIOR NUCLEUS; VOXEL BASED MORPHOMETRY;

ADULT; AGED; BRAIN; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARAHIPPOCAMPAL GYRUS; PARIETAL LOBE; POSTERIOR THALAMIC NUCLEI; TEMPORAL LOBE; YOUNG ADULT;

EID: 84860766271     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110833     Document Type: Article

References (40)

1. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 2002;58:1214-20. (Pubitemid 34411865)
2. Monastero R, Bettini P, Del Zotto E, Cottini E, Tincani A, Balestrieri G, et al. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci 2001;184:33-9. (Pubitemid 32166723)
3. Sibley JT, Olszynski WP, Decoteau WE, Sundaram MB. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 1992;19:47-52.
4. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9. (Pubitemid 26085211)
5. Appenzeller S, Pike GB, Clarke AE. Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol 2008;34:361-6.
6. Cotton F, Bouffard-Vercelli J, Hermier M, Tebib J, Vital Durand D, Tran Minh VA, et al. MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations. Rev Med Interne 2004;25:8-15. (Pubitemid 38229163)
7. Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, et al. Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus. J Rheumatol 2008;35:2348-54.
8. Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P. Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 2004;46:15-21. (Pubitemid 38248036)
9. Sibbitt WL Jr, Brooks WM, Kornfeld M, Hart BL, Bankhurst AD, Roldan CA. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 2010;40:32-52.
10. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narvaez A, Davila-Maldonado L, Atisha-Fregoso Y, Llorente L, et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007;56:1242-50. (Pubitemid 46608649)
11. Ballok DA, Woulfe J, Sur M, Cyr M, Sakic B. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus 2004;14:649-61. (Pubitemid 39107018)
12. Stanojcic M, Burstyn-Cohen T, Nashi N, Lemke G, Sakic B. Disturbed distribution of proliferative brain cells during lupus-like disease. Brain Behav Immun 2009;23:1003-13.
13. Appenzeller S, Bonilha L, Rio PA, Min Li L, Costallat LT, Cendes F. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus. Neuroimage 2007;34:694-701. (Pubitemid 44827765)
14. Jung RE, Segall JM, Grazioplene RG, Qualls C, Sibbitt WL, Roldan CA. Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus. PLoS One 2010;5:e9302.
15. Xu J, Cheng Y, Chai P, Lu Z, Li H, Luo C, et al. White-matter volume reduction and the protective effect of immunosuppressive therapy in systemic lupus erythematosus patients with normal appearance by conventional magnetic resonance imaging. J Rheumatol 2010;37:974-86.
16. Sundgren PC, Jennings J, Attwood JT, Nan B, Gebarski S, McCune WJ, et al. MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005;47:576-85. (Pubitemid 41258705)
17. Appenzeller S, Li LM, Costallat LT, Cendes F. Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus. Lupus 2007;16:963-71.
18. Shen YY, Kao CH, Ho YJ, Lee JK. Regional cerebral blood flow in patients with systemic lupus erythematosus. J Neuroimaging 1999;9:160-4.
19. Oda K, Matsushima E, Okubo Y, Ohta K, Murata Y, Koike R, et al. Abnormal regional cerebral blood flow in systemic lupus erythematosus patients with psychiatric symptoms. J Clin Psychiatry 2005;66:907-13. (Pubitemid 41032833)
20. Otte A, Weiner SM, Peter HH, Mueller-Brand J, Goetze M, Moser E, et al. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: A controlled positron emission tomography study. Eur J Nucl Med 1997;24:787-91. (Pubitemid 27356859)
21. Muscal E, Traipe E, de Guzman MM, Myones BL, Brey RL, Hunter JV. Cerebral and cerebellar volume loss in children and adolescents with systemic lupus erythematosus: A review of clinically acquired brain magnetic resonance imaging. J Rheumatol 2010;37:1768-75.
22. Appenzeller S, Carnevalle AD, Li LM, Costallat LT, Cendes F. Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum Dis 2006;65:1585-9. (Pubitemid 44799669)
23. Appenzeller S, Rondina JM, Li LM, Costallat LT, Cendes F. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum 2005;52:2783-9. (Pubitemid 41369107)
24. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26:839-51. (Pubitemid 40825026)
25. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
26. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
27. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
28. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
29. Predescu A, Damsa C, Riegert M, Bumb A, Pull C. Persistent psychotic disorder following bilateral mesencephalo-thalamic ischaemia: case report [in French]. Encephale 2004;30:404-7. (Pubitemid 39371405)
30. Mittal M, Khan S. Starvation causes acute psychosis due to anterior thalamic infarction. South Med J 2010;103:701-3.
31. Shioiri A, Kurumaji A, Takeuchi T, Matsuda H, Arai H, Nishikawa T. White matter abnormalities as a risk factor for postoperative delirium revealed by diffusion tensor imaging. Am J Geriatr Psychiatry 2010;18:743-53.
32. Reed LJ, Lasserson D, Marsden P, Stanhope N, Stevens T, Bello F, et al. FDG-PET findings in the Wernicke-Korsakoff syndrome. Cortex 2003;39:1027-45. (Pubitemid 37351080)
33. Hughes M, Sundgren PC, Fan X, Foerster B, Nan B, Welsh RC, et al. Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: A prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain. Acta Radiol 2007;48:213-22. (Pubitemid 46396995)
34. Santer DM, Yoshio T, Minota S, Moller T, Elkon KB. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol 2009;182:1192-201.
35. Okamoto H, Katsumata Y, Nishimura K, Kamatani N. Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum 2004;50:3731-2. (Pubitemid 39488704)
36. Duprez T, Nzeusseu A, Peeters A, Houssiau FA. Selective involvement of the choroid plexus on cerebral magnetic resonance images: A new radiological sign in patients with systemic lupus erythematosus with neurological symptoms. J Rheumatol 2001;28:387-91. (Pubitemid 32165156)
37. Amaro E Jr, Scheinberg M. Onset of cognitive dysfunction in systemic lupus erythematosus and selective involvement of the choroid plexus. J Rheumatol 2009;36:2554-5.
38. Schmidt-Wilcke T, Luerding R, Weigand T, Jurgens T, Schuierer G, Leinisch E, et al. Striatal grey matter increase in patients suffering from fibromyalgia - A voxel-based morphometry study. Pain 2007;132 Suppl 1:S109-16. (Pubitemid 350030865)
39. Soriano-Mas C, Hernandez-Ribas R, Pujol J, Urretavizcaya M, Deus J, Harrison BJ, et al. Cross-sectional and longitudinal assessment of structural brain alterations in melancholic depression. Biol Psychiatry 2011;69:318-25.
40. Zivadinov R, Reder AT, Filippi M, Minagar A, Stuve O, Lassmann H, et al. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology 2008;71:136-44.